Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease

被引:95
|
作者
Lin, Grace A.
Dudley, R. Adams
Redberg, Rita F.
机构
[1] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA
关键词
D O I
10.1001/archinte.167.15.1604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Percutaneous coronary intervention (PCI) is commonly performed in patients with stable coronary artery disease, despite current evidence suggesting that such patients derive minimal benefit from the procedure. We sought to determine the influences on cardiologists' decision to perform elective PCI in patients with stable coronary artery disease. Methods: We conducted a qualitative study using 3 focus groups of interventional and noninterventional cardiologists in California. Participants discussed issues surrounding the decision to perform PCI using hypothetical case scenarios. We analyzed the data according to the principles of grounded theory. Results: Despite acknowledging data showing that PCI offers no reduction in the risk of death or myocardial infarction in patients with stable coronary artery disease, cardiologists generally believed that PCI would benefit such patients. Reasons given for performing PCI included belief the benefits of treating ischemia and the open artery hypothesis, especially with drug-eluting stents; potential regret for not intervening if a cardiac event could be averted; alleviation of patient anxiety; and medicolegal considerations. Participants believed that, in patients undergoing coronary angiography, an "oculostenotic reflex" prevailed and all significant amenable stenoses would receive intervention, even in asymptomatic patients. Conclusions: The widespread application of PCI in stable coronary artery disease for indications unsupported by evidence may reflect discordance between cardiologists' clinical knowledge and their beliefs about the benefits of PCI. Nonclinical factors appear to have substantial influence on physician decision making. Future studies should focus on the development of methods to help providers more fully incorporate clinical evidence into their medical decision making.
引用
收藏
页码:1604 / 1609
页数:6
相关论文
共 50 条
  • [31] The Significance of Coronary Artery Calcification for Percutaneous Coronary Interventions
    Lis, Pawel
    Rajzer, Marek
    Klima, Lukasz
    HEALTHCARE, 2024, 12 (05)
  • [32] Effectiveness of Preprocedural Statin Therapy on Clinical Outcomes for Patients With Stable Coronary Artery Disease After Percutaneous Coronary Interventions
    Ko, Dennis T.
    Wijeysundera, Harindra C.
    Yun, Lingsong
    Austin, Peter C.
    Cantor, Warren J.
    Tu, Jack V.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (04): : 459 - 466
  • [33] Not just evidence-based: Physician decision making regarding percutaneous coronary interventions for stable coronary artery disease
    Lin, Grace A.
    Dudley, R. Adams
    Redberg, Rita F.
    CIRCULATION, 2007, 115 (21) : E552 - E553
  • [34] Usefulness of percutaneous coronary intervention for diabetic patients with stable coronary artery disease
    Fukuda, H.
    Moroi, M.
    Masai, H.
    Kunimasa, T.
    Nakazato, R.
    Furuhashi, T.
    Sugi, K.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A47 - A47
  • [35] Need for a moratorium on percutaneous transluminal coronary angioplasty in stable coronary artery disease
    Nash, DT
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (05): : 567 - +
  • [36] Percutaneous Coronary Intervention Versus Medical Therapy in Stable Coronary Artery Disease
    Epstein, Stephen E.
    Waksman, Ron
    Pichard, Augusto D.
    Kent, Kenneth M.
    Panza, Julio A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (10) : 993 - 998
  • [37] Post-percutaneous coronary intervention angina in stable coronary artery disease
    Beltrame, John F.
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2016, 2 (02) : 66 - 68
  • [38] Rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease
    Verheugt, F. W. A.
    Vranckx, P.
    Lindeboom, W.
    Kim, S. Y.
    Kirsch, B.
    Van Eickels, M.
    Leebeek, F. W. G.
    EUROPEAN HEART JOURNAL, 2014, 35 : 992 - 992
  • [39] How Cardiologists Present the Benefits of Percutaneous Coronary Interventions to Patients With Stable Angina A Qualitative Analysis
    Goff, Sarah L.
    Mazor, Kathleen M.
    Ting, Henry H.
    Kleppel, Reva
    Rothberg, Michael B.
    JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1614 - 1621
  • [40] Outcomes of Percutaneous Coronary Intervention for stable Coronary Artery Disease compared with Acute Coronary Syndromes
    Vranckx, P.
    Stefanini, G. G.
    Kalesan, B.
    Farooq, V.
    Onuma, Y.
    Silber, S.
    Juni, P.
    Serruys, P. W.
    Windecker, S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 353 - 354